Decreased circulatory microRNA-4478 as a specific biomarker for diagnosing non-ST-segment elevation myocardial infarction (NSTEMI) and its association with soluble leptin receptor | Zendy

Reza Gholikhani-Darbroud | Zendy; Fatemeh KhakiKhatibi | Zendy; Fatemeh Mansouri | Zendy; M. Hajahmadipoorrafsanjani | Zendy; Morteza Ghojazadeh | Zendy

Open Access

Decreased circulatory microRNA-4478 as a specific biomarker for diagnosing non-ST-segment elevation myocardial infarction (NSTEMI) and its association with soluble leptin receptor

Author(s) -

Reza Gholikhani-Darbroud,

Fatemeh KhakiKhatibi,

Fatemeh Mansouri,

M. Hajahmadipoorrafsanjani,

Morteza Ghojazadeh

Publication year - 2017

Publication title -

bratislavské lekárske listy/bratislava medical journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.387

H-Index - 32

eISSN - 1336-0345

pISSN - 0006-9248

DOI - 10.4149/bll_2017_129

Subject(s) - biomarker , myocardial infarction , medicine , endocrinology , biology , biochemistry

This study aimed to assess the usefulness of circulatory microRNA-4478 (miR-4478) and soluble leptin receptor (sLEPR) in prognosis and diagnosis of non-ST-segment elevation myocardial infarction (NSTEMI) and to introduce miR-4478 as a new biomarker for NSTEMI disease. This study aimed also to examine correlation between miR-4478 and soluble leptin receptor and effects of miR-4478 on leptin receptor concentration.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research